C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) A61K 31/52 (2006.01) A61K 31/70 (2006.01) C07D 405/04 (2006.01) C07D 405/14 (2006.01) C07D 473/00 (2006.01) C07F 7/18 (2006.01) C07H 19/04 (2006.01) C07H 19/06 (2006.01) C07H 19/10 (2006.01) C07H 19/16 (2006.01) C07H 23/00 (2006.01)
Patent
CA 2103378
2103378 9220822 PCTABS00017 Therapeutic oligonucleotide analogs which have nuclease resistance and improved cellular uptake are provided. Replacement of posphorodiester inter-sugar linkages found in wild type oligomers with four atom linking groups forms unique di- and polynucleosides and nucleotides useful in regulating RNA expression and in therapeutics. Methods of synthesis and use are also disclosed.
Cook Phillip Dan
Debart Francoise
Sanghvi Yogesh Shantilal
Vasseur Jean Jacques
Isis Pharmaceuticals Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Backbone modified oligonucleotide analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Backbone modified oligonucleotide analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Backbone modified oligonucleotide analogues will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1370469